Arteriovenous Fistula Devices Market Growth and Insights: FDA Approvals, Technological Advances, and Market Forecasts Driving Industry Expansion to 2030

The Arteriovenous Fistula Market is estimated at USD 1.15 billion in 2025 and is projected to reach USD 1.65 billion by 2030, growing at a CAGR of 5.9% during 2023-2030.

Arteriovenous Fistula Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/arteriovenous-fistula-market?un

The Arteriovenous Fistula (AVF) Market refers to the healthcare sector focused on the creation, treatment, and management of arteriovenous fistulas surgically created connections between an artery and a vein, primarily used for hemodialysis in patients with chronic kidney disease. This market encompasses surgical procedures, vascular grafts, catheters, medical devices, and supportive therapies. Growth is driven by the increasing prevalence of end-stage renal disease (ESRD), rising demand for dialysis access procedures, advancements in minimally invasive techniques, and ongoing innovations in vascular access devices to improve patient outcomes and reduce complications.

Industry News of USA and Japan:

USA Key Developments

• The WAVE (WRAPSODY Arteriovenous Access Efficacy) pivotal trial recently released its Anual results, showing a statistically significant improvement in target lesion primary patency (TLPP), signaling promising longevity and effectiveness of AVF interventions in clinical settings.

• Medtronic's IN.PACT AV drug-coated balloon (DCB) received FDA approval for treating failing AV access in ESRD patients undergoing dialysis. Clinical data demonstrated that its use reduced the need for reinterventions by 56% over six months compared to standard angioplasty, enhancing AVF maintenance outcomes.

• Concept Medical was granted its fifth US FDA IDE approval for its MagicTouch AVF sirolimus-coated balloon to treat stenotic AVF lesions, paving the way for pivotal trials and eventual PMA submission in the US market.

Japan Key Developments

• In a Japanese cohort of the IN.PACT AV Access trial, drug-coated balloons (DCBs) achieved a much higher 12-month TLPP rate (67.3%) compared to standard angioplasty (43.4%), demonstrating improved effectiveness in AVF lesion treatment among Japanese patients.

• Regulatory reform continues to gain momentum. The Japanese Health Ministry panel recently recommended measures to enhance and facilitate Japan's conditional approval processes, with plans to finalize these proposals by December for submission to the Diet in the next legislative cycle.


Key Players:

• Pervasis Therapeutics, Inc.,

• Proteon Therapeutics, Inc.,

• Medtronic,

• Cook Medical,

• Fresenius Medical Care AG & Co. KGaA,

• Poly Medicure Limited,

• Becton Dickinson and Company,

• Braun Melsungen Ag,

• Teleflex

Growth Forecast Projected:

The Global Arteriovenous Fistula Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Arteriovenous Fistula Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=arteriovenous-fistula-market

Market Segmentation:

➤ By Type: Radial Cephalic fistula, Brachial Cephalic, Brachial Basilic Transposition.

➤ By Treatment Methods: Endovascular embolization, Microsurgery, Stereotactic radiosurgery.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/arteriovenous-fistula-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Arteriovenous Fistula Market?

➠ Who are the leading manufacturers in the global Digital Diabetes industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Digital Diabetes industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Arteriovenous Fistula Market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.